J&J pauses vaccine trials due to unexplained illness

    An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. - The US pharmaceutical industry faces tens of billions of dollars in potential damage payments for fueling the opioid addiction crisis after Oklahoma won a $572 million judgment against drugmaker Johnson & Johnson. (Photo by Mark RALSTON / AFP) (Photo credit should read MARK RALSTON/AFP via Getty Images)

    Johnson & Johnson said on Monday it has temporarily paused its covid-19 vaccine candidate clinical trials due to an unexplained illness in a study participant. The participant’s illness is being reviewed and evaluated by an independent data and safety monitoring board as well as the company’s clinical and safety physicians, it said in a statement.

    Stat News reported the pause earlier in the day citing a document sent to outside researchers running the 60,000-patient clinical trial, which stated that a ‘pausing rule’ had been met, the online system used to enroll patients in the study had been closed and the data and safety monitoring board would be convened.



    Please enter your comment!
    Please enter your name here

    This site uses Akismet to reduce spam. Learn how your comment data is processed.